Encompass Health Corporation Common Stock (EHC)

Johnson Fistel, PLLP is investigating potential claims for investors of Encompass Health Corporation (NYSE: EHC) over possible violations of federal securities laws. Investors may be eligible to recover losses from alleged misrepresentations or omissions by the company and its executives.

NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) --

Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Them Directly To Discuss Their Options

NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Sept. 01, 2025 (GLOBE NEWSWIRE) --

NEW YORK, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options

Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Encompass Health Corporation (NYSE: EHC) resulting from allegations that Encompass Health may have issued materially misleading business information to the investing public.

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options

NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Encompass (EHC), National Grid (NGG), or Quantum (QMCO) To Contact Him Directly To Discuss Their Options

NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

RADNOR, PA - July 21, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Encompass Health Corporation ( NYSE: EHC ) (“Encompass Health”).

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass Health” or “the Company”) (NYSE: EHC) for violations of the securities laws.

RADNOR, PA - July 18, 2025 ( NEWMEDIAWIRE ) - The law firm of Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ) is currently investigating potential violations of the federal securities laws on behalf of investors of Encompass Health Corporation ( NYSE: EHC ) (“Encompass Health”).

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.